17 beta-estradiol inhibits cardiac fibroblast growth through both subtypes of estrogen receptor.
17 beta-estradiol inhibits cardiac fibroblast growth through both subtypes of estrogen receptor.
复制标题
DOI:
10.1016/j.bbrc.2003.09.232
复制
发表时间:
2003-11
影响因子:
3.1
通讯作者:
Tokumitsu Watanabe;M. Akishita;Hong He;Y. Miyahara;K. Nagano;T. Nakaoka;N. Yamashita;K. Kozaki;Y. Ouchi
中科院分区:
文献类型:
--
作者:
Tokumitsu Watanabe;M. Akishita;Hong He;Y. Miyahara;K. Nagano;T. Nakaoka;N. Yamashita;K. Kozaki;Y. Ouchi
The effect of 17β-estradiol (E2) on the proliferation of cardiac fibroblasts (CFs) remains controversial. This study investigated which subtype of estrogen receptor (ER), ERα or ERβ, mediated the effect of E2 on CF growth by the gain of function analysis using an adenovirus vector. One hundred nanomoles per liter of E2 attenuated DNA synthesis by up to 10%, and transactivated the estrogen-responsive element determined by luciferase assay in rat neonatal CFs. We constructed replication-deficient adenoviruses bearing the coding region of human ERα, ERβ, or the dominant-negative form of ERβ (designated AxCAERα, AxCAERβ, and AxCADNERβ, respectively). When CFs were infected with AxCAERα or AxCAERβ at multiplicity of infection of 20 or higher, DNA synthesis was decreased by 50% in response to E2 and the effect was abolished by co-infection with AxCADNERβ. Similarly, transcriptional activity of ER in CFs infected with AxCAERα or AxCAERβ was markedly enhanced and co-infection with AxCADNERβ abolished the effects. These results suggest that E2 inhibits CF growth and that both ER subtypes mediate the effect comparably and redundantly.